1N L Harris,E S Jaffe,J Diebold,G Flandrin,H K Muller-Hermelink,J Vardiman,T A Lister,C D Bloomfield,张凤奎,郝玉书.世界卫生组织(WHO)造血与淋巴组织肿瘤分类方案:临床顾问委员会会议报告[J].白血病．淋巴瘤,2001,10(3):171-181. 被引量：20
5Harbott J, Mancini M, Verellen-Dumoulin C, et al. Hematological malignancies with a deletion of 11 q23 :cytogenetic and clinical aspects. European 11 q23 Workshop participants [ J ]. Leukemia,1998,12 (5) :823 - 827.
6Johansson B, Moorman AV, Haas OA, et al. Hematologic malignancies with t (4 ; 11 ) ( q21 ; q23 ) - a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants [ J ]. Leukemia, 1998,12 ( 5 ) :779 - 787.
7The Groupe Francais de Cytogenetique Hematologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique [J]. Blood, 1996,87(8) :3135 -3142.
8Cimino G, Elia L, Mancini M, et al. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study:absence of the ALL1/AF4 and of the BCR/ ABL fusion genes correlates with a significantly better clinical outcome [ J ]. Blood ,2003,102 (6) :2014 - 2020.
9Swansbury G J, Slater R, Bain B J, et al. Hematological malignancies with t (9 ; 11 ) ( p21 - 22 ; q23 ) - a laboratory and clinical study of 125 cases. European 11 q23 Workshop participants [ J ]. Leukemia, 1998,12 ( 5 ) :792 - 800.
10Chillon CM ,Garcia-Sanz R, Balanzategui A, et al. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification:a different distribution in Central-West Spain [J]. Haematologica,2001,86(2 ) : 162 - 166.
